Gene knockout mice as investigative tools in pathophysiology

International Journal of Experimental Pathology

Volumn 77, Issue 4, 1996, Pages 125-141

  Ryffel, Bernhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL TISSUE; ARTHRITIS; CONTROLLED STUDY; DISEASE MODEL; GENE DELETION; GENETIC RECOMBINATION; GLOMERULONEPHRITIS; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029830824     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1996.d01-215.x     Document Type: Review

References (98)

1. ALEXANDER H.R., WONG G.G., DOHERTY G.M., VENZON D.J., FRAKER D.L. & NORTON J.A. (1992) Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J. Ex. Med. 175, 1139-1142.
2. AREND W.P. & DAYER J.M. (1995) Inhibition of the production and effects of interleukin-1 and tumour necrosis factor in rheumatoid arthritis. Arthritis Rheumatism 2, 151-160.
3. BANKS T.A., ROUSE B.T., KERLEY M.K., BLAIR P.J., GODFREY V.L., KUKLIN N.K., BOULEY D.M., THOMAS J., KANANGAT S. & MUCENSKI M.L. (1995) Lymphotoxin-a deficient mice. J. Immunol. 155, 1685-1693.
4. BAUMANN, H. & GAULDIE J. (1994) The acute phase response. Immunol. Today 15, 74-80.
5. BEUTLER B. & VAN-HUFFEL C. (1994) Unraveling function in the TNF ligand and receptor families [comment]. Science 264, 667-668.
6. BLOCK M.I., BERG M., MCNAMARA M.J., NORTON J.A., FRAKER D.L. & ALEXANDER H.R. (1993) Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 178, 1085-1090.
7. BRENNAN F.M. (1994) Role of cytokines in experimental arthritis. Clin. Exp. Immunol. 97, 1-3.
8. BROWNING J.L., NGAM-EK A., LAWTON P., DEMARINIS J., TIZARD R., CHOW E.P., HESSION C., O'BRINE-GRECO B., FOLEY S.F. & WARE C.F. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72, 847-856.
9. BULLARD D., QIN L., LORENZO I., QUINLIN W. & DOYLE W. (1995) P-Selectin/ICAM-1 double mutant mice: Acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J. Clin. Invest. 95, 1782-1788.
10. CALCALANO G., LEE J., KIKLY K., RYAN A.M., PITTS-MEEK S., HULTGREN B., WOOD W.I. & MOORE M.W. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682-684.
11. CAO X., SHORES E., HU-LI J., ANVER M. & KEISALL B. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2, 223-238.
12. CAR B.D., ENG, V.M., SCHNYDER B., OZMEN L., HUANG S., GALLAY P., HEUMANN D., AGUET M. & RYFFEL B. (1994) Interferon gamma receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437-1444.
13. CASTIGLI E., ALT F.W., DAVIDSON L., BOTTARO A., MIZOGUCHI E., BHAN A.K. & GEHA R.S. (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. U.S.A. 91, 12135-12139.
14. CROWE P.D., VANARSDALE T.L., WALTER B.N., WARE C.F., HESSION C., EHRENFELS B., BROWNING J.L., DIN W.S., GOODWIN R.G. & SMITH C.A. (1994) A lymphotoxin-beta-specific receptor [see comments]. Science 264, 707-710.
15. DALTON D.K., PITTS-MEEK S., KESHAV S., FIGARI I.S., BRADLEY A. & STEWART T.A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes [see comments]. Science 259, 1739-1742.
16. DARNELL J., JR., KERR I.M. & STARK G.R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
17. DE-TOGNI P., GOELLNER J., RUDDLE N.H., STREETER P.R., FICK A., MARIATHASAN S., SMITH S.C., CARLSON R., SHORNICK L.P., STRAUSS-SCHOENBERGER J. & ET CHAPLIN D. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin [see comments]. Science 264, 703-707.
18. DISANTO J.P., MULLER W., GUY-GRAND D., FISCHER A. & RAJEWSKY K. (1995) Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. U.S.A. 92, 377-381.
19. ERICKSON S.L., DE-SAUVAGE F.J., KIKLY K., CARVER-MOORE K., PITTSMEEK S., GILLETT N., SHEEHAN K.C., SCHREIBER R.D., GOEDDEL D.V. & MOORE M.W. (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
20. ESCARY J.L., PERREAU J., DUMENIL D., EZINE S. & BRULET P. (1993) Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363, 361-364.
21. EUGSTER H.P., MULLER M., KARRER U., CAR B.D., SCHNYDER B., ENG V.M., WOERLY G., DI PADOVA F., AGUET M., ZINKERNAGEL R., BLUETHEMANN H. & RYFFEL B. (1996) Multiple immune abnormalities in TNF and LTa double deficient mice. Int. Immunol. 8, 23-36.
22. FATTORI E., CAPPELLETTI M., COSTA P., SELLITTO C., CANTONI L., CARELLI M., FAGGIONI R., FANTUZZI G., GHEZZI P. & POLI V. (1994) Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180, 1243-1250.
23. FELDMANN M., BRENNAN F.M. & MAINI R.N. (1996) Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol. 14, 392-440.
24. FLESCH I.E., HESS J.H., HUANG S., AGUET M., ROTHE J., BLUETHMANN H. & KAUFMANN S.H. (1995) Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181, 1615-1621.
25. GEARING A.J., BECKETT P., CHRISTODOULOU M., CHURCHILL M., CLEMENTS J.M., CRIMMIN M., DAVIDSON A.M., DRUMMOND A.H., GALLOWAY W.A., GILBERT W.A. & GILBERT R. (1995) Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukoc. Biol. 57, 774-777.
26. GORDON J., KATIRA A., HOLDER M., MACDONALD I. & POUND J. (1994) Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens. Cell. Mol. Biol. Noisyle-grand 1, 1-13.
27. GRAU, G.E., FAJARDO L., PIGUET P.F., ALLET B., LAMBERT P.H. & VASALLI P. (1987) Tumor necrosis factor as an essential mediator in murine cerebral malaria. Science 237, 1210-1212.
28. GRAU G.E., LAMBERT P.H., VASSALLI P. & PIGUET P.F. (1993) Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology. Int. Rev. Exp. Pathol. 34, 159-171.
29. GRELL M., DOUNI E., WAJANT H., LÖHDEN M., GEORGOPOULOS S., LESSLAUER W., KOLLIAS G., PFIZENMAIER K. & P.S. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
30. GU H., MARTH J.D., ORBAN P.C., MOSSMANN H. & RAJEWSKY K. (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting [see comments]. Science 265, 103-106.
31. HAAS G., RYFFEL B., AGUET M. & M.L.H. (1995) MHC antigens in interferon g receptor deficient mice: IFNg-independent up-regulation of MHC clas II in renal tubules. Kidney Int. 48, 1721-1727.
32. HEMMI S., BOHNI R., STARK G., DI-MARCO F. & AGUET M. (1994) A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell 76, 803-810.
33. HEMMI S., PEGHINI P., METZLER M., MERLIN G., DEMBIC Z. & AGUET M. (1989) Cloning of murine interferon gamma receptor cDNA: expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 86, 9901-9905.
34. HIROTA H., YOSHIDA K., KISHIMOTO T. & TAGA T. (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. U.S.A. 92, 4862-4866.
35. HUANG P.L., DAWSON T.M., BREDT D.S., SNYDER S.H. & FISHMAN M.C. (1993a) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273-1286.
36. HUANG S., HENDRIKS W., ALTHAGE A., HEMMI S., BLUETHMANN H., KAMIJO R., VILCEK J., ZINKERNAGEL R.M. & AGUET M. (1993b) Immune response in mice that lack the interferon-gamma receptor [see comments]. Science 259, 1742-1745.
37. HUANG Z., HUANG P.L., PANAHIAN N., DALKARA T., FISHMAN M.C. & Moskowitz M.A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
38. JACKSON S.H., GALLIN J.I. & HOLLAND S.M. (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751-758.
39. JACOB C.O. & MCDEVITT H.O. (1988) Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 331, 356-358.
40. JACOB C.O., VAN DER MEIDE P.H. & MCDEVITT M.O. (1987) Prevention of murine autoimmune 'lupus' nephritis by neutralising interferon-gamma antibodies. J. Exp. Med. 166, 798-804.
41. KAGI D., LEDERMANN B., BURKI K., SEILER P., ODERMATT B., OLSEN K.J., PODACK E.R., ZINKERNAGEL R.M. & HENGARTNER H. (1994a) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice [see comments]. Nature 369, 31-37.
42. KAGI D., VIGNAUX F., LEDERMANN B., BURKI K., DEPRAETERE V., NAGATA S., HENGARTNER H. & GOLSTEIN P. (1994b) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
43. KAUFMANN S.H. (1994) Bacterial and protozoal infections in genetically disrupted mice. Curr. Opin. Immunol. 6, 518-525.
44. KEFFER J., PHOBERT L., CAZLARIS H., GEORGOPOULOS S., KASLARIS E., KIOUSSIS D. & KOLLIAS G. (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025-4031.
45. KOPF M., BAUMANN H., FREER G., FREUDENBERG M., LAMERS M., KISHIMOTO T., ZINKERNAGEL R., BLUETHMANN H. & KOHLER G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
46. KOPF M., LE-GROS G., BACHMANN M., LAMERS M.C., BLUETHMANN H. & KOHLER G. (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
47. KUHN R., LOHLER J., RENNICK D., RAJEWSKY K. & MULLER W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 75, 263-274.
48. KUHN R., RAJEWSKY K. & MULLER W. (1991) Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
49. KUIDA K., LIPPKE J., KU G., HARDING M., LIVINGSTON D. & SU M. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1beta converting enzyme. Science 267, 2000-2002.
50. KULKARNI A.B., HUH C.G., BECKER D., GEISER A., LYGHT M., FLANDERS K.C., ROBERTS A.B., SPORN M.B., WARD J.M. & KARLSSON S. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90, 770-774.
51. KULKARNI A.B. & KARLSSON S. (1993) Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143, 3-9.
52. KUNDIG T.M., SCHORLE H., BACHMANN M.F., HENGARTNER H., ZINKERNAGEL R.M. & HORAK I. (1993) Immune responses in interleukin-2-deficient mice. Science 262, 1059-1061.
53. LE HIR M., BLUETHMANN H., KOSCO-VILBOIS M.H., MULLER M., DI PADOVA F., MOORE M., RYFFEL B. & EUGSTER H.P. (1996) Differentiation of follicular dendritic cells and full antibody responses require TNF receptor-1 signalling. J. Exp. Med. 184, 2367-2372.
54. LEONARD W.J., NOGUCHI M., RUSSELL S.M. & MCBRIDE O.W. (1994) The molecular basis of X-linked severe combined immuno-deficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Immunol. Rev. 138, 61-86.
55. LI P., ALLEN H., BANERJEE S., FRANKLIN S., HERZOG L., JOHNSTON C., MCDOWELL J., PASKIND M., RODMAN L., SALFELD J. et al. (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80, 401-411.
56. MACMICKING J., NATHAN D., HOM D., CHARTRAIN N. & FLETSCHER D. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
57. MAGRAM J., CONNAUGHTON S.E., WARRIER R.R., CARRAJAD O.M., WIN C.H., TERRULE J., STEWART C., SARMIENTO C., FLAHERTY O.A. & GATELY M.K. (1996) Immunity 4, 471-478.
58. MAYADAS T.N., JOHNSON R.C., RAYBURN H., HYNES R.O. & WAGNER D.D. (1993) Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74, 541-554.
59. MIYAWAKI S., NAKAMURA Y., SUZUKA H., KOBA M., YASUMIZU R., IKEHARA S. & SHIBATA Y. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immuno-deficiency in mice. Eur. J. Immunol. 24, 429-434.
60. MOSMANN T.R. & COFFMAN R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
61. MULLER M., EUGSTER H.P., LE HIR M., SHAKHOV A., DI PADOVA F., MAURER C., QUESNIAUX V.J.F. & RYFFEL B. (1996) Correction and transfer of immunodeficiency of TMF-LT deficiency by bone marrow transplantation. Mol. Med. 2, 247-255.
62. MULLER U., STEINHOFF U., REIS L.F., HEMMI S., PAVLOVIC J., ZINKERNAGEL R.M. & AGUET M. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
63. NAGATA S. (1994) Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57, 129-144.
64. NAGATA S. & GOLSTEIN P. (1995) The Fas death factor. Science 267, 1449-1456.
65. NOVOGRODSKY A., VANICHKIN A., PATYA M., GAZIT A., OSHEROV N. & LEVITZKI A. (1994) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264, 1319-1322.
66. OZMEN L., ROMAN D., FOUNTOULAKIS M., SCHMID G., RYFFEL B. & GAROTTA G. (1995) Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25, 6-12.
67. PFEFFER K., MATSUYAMA T., KUNDIG T.M., WAKEHAM A., KISHIHARA K., SHAHINIAN A., WIEGMANN K., OHASHI P.S., KRONKE M. & MAK T.W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
68. PIGUET P.F. (1993) Cytokines involved in pulmonary fibrosis. Int. Rev. Exp. Pathol. 34B, 173-181.
69. PIGUET P.F., TACCHINI COTTIER F. & VESIN C. (1995) Administration of anti-TNF-alpha or anti-CD11a antibodies to normal adult mice decreases lung and bone collagen content: evidence for an effect on platelet consumption. Am. J. Respir. Cell Mol. Biol. 12, 227-231.
70. POLI V., BALENA R., FATTORI E., MARKATOS A., YAMAMOTO M., TANAKA H., CILIBERTO G., RODAN G.A. & COSTANTINI F. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. Embo. J. 13, 1189-1196.
71. RAMSAY A.J., HUSBAND A.J., RAMSHAW I.A., BAO S., MATTHAEI K.I., KOEHLER G. & KOPF M. (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561-563.
72. RENSHAW B.R., FANSLOW W.R., ARMITAGE R.J., CAMPBELL K.A., LIGGITT D., WRIGHT B., DAVISON B.L. & MALISZEWSKI C.R. (1994) Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
73. ROTHE J., LESSLAUER W., LOTSCHER H., LANG Y., KOEBEL P., KONTGEN F., ALTHAGE A., ZINKERNAGEL R., STEINMETZ M. & BLUETHMANN H. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
74. RYFFEL B., CAR B.D., WOERLY G., WEBER M., DIPADOVA F., KAMMULLER M., KLUG S., NEUBERT R. & NEUBERT D. (1994) Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate - the marmoset. Blood 83, 2093-2102.
75. RYFFEL B., MIHATSCH M.J. & WOERLY G. (1993) Pathology induced by interleukin-6. Int. Rev. Exp. Pathol. 34, 79-89.
76. SADLACK B., MERZ H., SCHORLE H., SCHIMPL A., FELLER A.C. & HORAK I. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene [see comments]. Cell 75, 253-261.
77. SCHORLE H., HOLTSCHKE T., HUNIG T., SCHIMPL A. & HORAK I. (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624.
78. SHULL M.M., ORMSBY I., KIER A.B., PAWLOWSKI S., DIEBOLD R.J., YIN M., ALLEN R., SIDMAN C., PROETZEL G., CALVIN D, & et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
79. SPRINGER T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
80. STEWART C.L., KASPAR P., BRUNET L.J., BHATT H., GADI I., KONTGEN F. & ABBONDANZO S.J. (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor [see comments]. Nature 359, 76-79.
81. STROBER W. & EHRHARDT R.O. (1993) Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice [comment]. Cell 75, 203-205.
82. SUBRAMANIAM M., SAFFARIPOUR S., WATSON S., MAYADAS T. & HYNES R. (1995) Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J. Exp. Med. 181, 2277-2282.
83. SUEMATSU S., MATSUDA T., AOZASA K., AKIRA S., NAKANO N., OHNO S., MIYAZAKI J., YAMAMURA K., HIRANO T. & KISHIMOTO T. (1989) IgGl plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 86, 7547-7551.
84. SUZUKI H., KUNDIG T., FURLONGER C., WAKEHAM A., TANIGUCHI T., PAGE C. & MAK T. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472-1475.
85. TAKAHASHI T., TANAKA M., INAZAWA J., ABE T., SUDA T. & NAGATA S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567-1574.
86. TANAKA T., AKIRA S., YOSHIDA K., UMEMOTO M., YONEDA Y., SHIRAFUJI N., FUJIWAHA H., SUEMATSU S., YOSHIDA N. & KISHIMOTO T. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
87. TEDDER T., STEEBER D. & PIZCUETA P. (1995) L-Selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181, 2259-2264.
88. TRACEY K.J. & CERAMI A. (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503.
89. TRINCHIERI G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
90. TRINCHIERI G. (1995) Interleukin 12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
91. VAJDY M., KOSCO V.M., KOPF, M., KOHLER G. & LYCKE N. (1995) Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181, 41-53.
92. VON FREEDEN JEFFRY U., VIEIRA P., LUCIAN L.A., MCNEIL T., BURDACH S.E. & MURRAY R. (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
93. WEI X., CHARLES I., SMITH A., URE J. & FENG G. (1995) Altered immune response in mice lacking inducible nitric oxide synthase. Nature 375, 408-410.
94. WILLIAMS R.O., FELDMANN M. & MAINI R.N. (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A. 89, 9784-9788.
95. XU H., GONZALO J.A., ST-PIERRE Y., WILLIAMS I.R., KUPPER T.S., COTRAN R.S., SPRINGER T.A. & GUTIERREZ-RAMOS J.C. (1994) Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180, 95-109.
96. YEUNG R.S., PENNINGER J. & MAK T.W. (1994) T-cell development and function in gene-knockout mice. Curr. Opin. Immunol. 6, 298-307.
97. YOSHIDA K., TAGA T., SAITO M., SUEMATSU S., KUMANOGOH A., TANAKA T., FUJIWARA H., HIRATA M., YAMAGAMI T., NAKAHATA T., HIRABAYASHI T., YONEDA Y., TANAKA K., WANG W.Z., MORI C., SHIOTA K., YOSHIDA N. & KISHIMOTO T. (1996) Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematoloigcal disorders. Proc. Natl. Acad. Sci. U.S.A. 93, 407-411.
98. ZHENG H., FLETCHER D., KOZAK W., HOFMANN K.J.J., M., TOCCI M.J. & PLEOGH V.D. (1995) Resistance to fever induction and impaired acute-phase response in interleukin-1beta-deficient mice. Immunity 3, 9-19.